0
     

Report Added
Report already added
Sepsis Diagnostics: Global Markets

Sepsis Diagnostics: Global Markets

Report Scope:

The current report provides detailed exposure to the sepsis diagnostic market. This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities. The report also covers market projections to 2026 and market shares for key market players. It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type. The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.

The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.

Report Includes:

- 35 data tables and 15 additional tables
- An updated overview of the global sepsis diagnostics market
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
- Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
- Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
- Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
- Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc.
Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Technology Background
Introduction
Causes
Risk Factors
Symptoms
Pathophysiology
Endothelial Dysfunction
Coagulopathy
Cardiovascular Dysfunction
Cellular Dysfunction
Epidemiology and Economic Burden
Diagnosis and Treatment
Regulatory Scenario
Regulations in North America
European Regulations
Chapter 4 Market Dynamics
Factors Affecting the Sepsis Diagnostic Market
Market Drivers
Increasing Incidence of Infectious Diseases
Rising Aging Population and Increasing Incidence of Chronic Diseases
Increasing Government Initiatives
Technological Developments
Market Restraints
High Cost of Instruments and Lack of Skilled Workforce
Opportunities
Demand for Rapid and Accurate Diagnostic Tool
Chapter 5 Impact of COVID-19
Introduction
Outbreak
COVID-19 Symptoms
COVID-19 Progression
Incubation Period
Epidemiology
Collaboration Between Organizations and Governments
Spread of Disease
Impact of COVID-19 on the Sepsis Diagnostic Market
Chapter 6 Sepsis Diagnostic Market by Technology
Global Sepsis Diagnostic Market by Technology
Microbiological Tests
Immunoassays
Molecular Diagnostics
Others
Chapter 7 Sepsis Diagnostic Market by Product
Assays and Reagents
Culture Media
Instruments
Software
Chapter 8 Sepsis Diagnostic Market by Method
Conventional Diagnostics
Automated Diagnostics
Chapter 9 Sepsis Diagnostic Market by Test Type
Laboratory Tests
Point-of-Care Tests
Chapter 10 Sepsis Diagnostic Market by Pathogen Type
Bacterial Sepsis
Fungal Sepsis
Others
Chapter 11 Sepsis Diagnostic Market by End User
Hospitals and Clinics
Diagnostic Centers
Academic and Research Institutions
Chapter 12 Sepsis Diagnostic Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 13 Competitive Landscape and Analysis of Market Opportunities
Recent Developments
Mergers, Acquisitions and Collaborations
Sepsis Diagnostic Company Market Shares
Chapter 14 Company Profiles
ABBOTT LABORATORIES
AXIS-SHIELD DIAGNOSTICS LTD.
BECTON, DICKINSON & COMPANY
BIOMERIEUX
BRUKER CORP.
DANAHER
EKF DIAGNOSTICS HOLDINGS PLC
IMMUNEXPRESS
LUMINEX CORP.
QIAGEN NV
ROCHE DIAGNOSTICS CORP.
SEEGENE
SIEMENS HEALTHINEERS AG
T2 BIOSYSTEMS
THERMO FISHER SCIENTIFIC INC.

List of Tables
Summary Table B : Global Sepsis Diagnostic Market, by Region, Through 2026
Summary Table A : Global Sepsis Diagnostic Market, Through 2026
Table 1 : Diagnostic Test Types and Regulation
Table 2 : COVID-19 Clinical Symptom Distribution
Table 3 : COVID-19 Confirmed Cases and Deaths, by WHO Region, April 1, 2022
Table 4 : Global Sepsis Diagnostic Market, Through 2026
Table 5 : Global Sepsis Diagnostic Market, by Technology, Through 2026
Table 6 : Global Sepsis Diagnostic Market for Microbiological Tests, by Region, Through 2026
Table 7 : Global Sepsis Diagnostic Market for Immunoassays, by Region, Through 2026
Table 8 : Global Sepsis Diagnostic Market for Molecular Diagnosis, by Region, Through 2026
Table 9 : Global Sepsis Diagnostic Market for Other Technology, by Region, Through 2026
Table 10 : Global Sepsis Diagnostic Market, by Product Type, Through 2026
Table 11 : Global Sepsis Diagnostic Market for Assays and Reagents, by Region, Through 2026
Table 12 : Global Sepsis Diagnostic Market for Culture Media, by Region, Through 2026
Table 13 : Global Sepsis Diagnostic Market for Instruments, by Region, Through 2026
Table 14 : Global Sepsis Diagnostic Market for Software, by Region, Through 2026
Table 15 : Global Sepsis Diagnostic Market, by Method Type, Through 2026
Table 16 : Global Sepsis Diagnostic Market for Conventional Methods, by Region, Through 2026
Table 17 : Global Sepsis Diagnostic Market for Automated Methods, by Region, Through 2026
Table 18 : Global Sepsis Diagnostic Market, by Test Type, Through 2026
Table 19 : Global Sepsis Diagnostic Market for Laboratory Tests, by Region, Through 2026
Table 20 : Global Sepsis Point-of-Care Test Diagnostic Market, by Region, Through 2026
Table 21 : Global Sepsis Diagnostic Market, by Pathogen Type, Through 2026
Table 22 : Global Bacterial Sepsis Market, by Region, Through 2026
Table 23 : Global Fungal Sepsis Market, by Region, Through 2026
Table 24 : Global Sepsis by Other Pathogens Market, by Region, Through 2026
Table 25 : Global Sepsis Diagnostic Market, by End User, Through 2026
Table 26 : Global Sepsis Diagnostic in Hospitals and Clinics Market, by Region, Through 2026
Table 27 : Global Sepsis Diagnostics in Diagnostic Centers Market, by Region, Through 2026
Table 28 : Global Sepsis Diagnostics in Academic and Research Institutions Market, by Region, Through 2026
Table 29 : Global Sepsis Diagnostic Market, by Region, Through 2026
Table 30 : Mergers, Acquisitions and Collaborations Portfolio, 2020-2022
Table 31 : Abbott Laboratories: Business Segment
Table 32 : Abbott Laboratories: Financials, 2018-2020
Table 33 : Becton, Dickinson & Company: Business Segment
Table 34 : Becton, Dickinson & Company: Financials, 2018-2020
Table 35 : BioMerieux SA: Sepsis Product Portfolio
Table 36 : BioMerieux SA: Financials, 2018-2020
Table 37 : Bruker Corp.: Financials, 2018-2020
Table 38 : Danaher: Business Segment
Table 39 : Danaher: Financials, 2018-2020
Table 40 : EKF Diagnostics Holdings PLC: Business Segment
Table 41 : Luminex: Product Portfolio
Table 42 : Roche Diagnostics Corp.: Product Segment
Table 43 : Roche Diagnostics Corp.: Financial Performance, 2018-2020
Table 44 : Roche Diagnostics Corp.: Key Developments
Table 45 : Siemens Healthineers AG: Business Segment
Table 46 : T2 Biosystems: Product Portfolio
Table 47 : T2 Biosystems: Key Developments
Table 48 : Thermo Fisher Scientific Inc.: Business Segments
Table 49 : Thermo Fisher Scientific Inc.: Financial Performance, 2018-2020

Report Title: Sepsis Diagnostics: Global Markets


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline